HIV-Tat protein activates c-Jun N-terminal kinase and activator protein- 1

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 776-781

  Kumar, Ashok ^a   Manna, Sunil K ^a   Dhawan, Subhash ^b   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Center for Biologics Evaluation/Res   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; SYNAPSIN I; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE TRANSFER; NONHUMAN; PRIORITY JOURNAL;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE; ENZYME ACTIVATION; FREE RADICALS; GENE PRODUCTS, TAT; GENES, TAT; HIV-1; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASES; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 0032528334     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Jones, K. A. 1993. Tat and the HIV-1 promoter. Curr. Opin. Cell Biol. 5:461.
2. Vaishnav, Y. N., and F. Wong-Staal. 1991. The biochemistry of AIDS. Annu. Rev. Biochem. 60:577.
3. Dayton, A. I., J. G. Sodrodki, C. A. Rosen, W. C. Goh, and W. A. Haseltine. 1986. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 44:941.
4. Howcroft, T. K., L. A. Palmer, J. Brown, B. Rellahan, F. Kashanchi, J. N. Brady, and D. S. Singer. 1995. HIV Tat represses transcription through Sp1-like elements in the basal promoter. Immunity 3:127.
5. Rautonen J., N. Rautonen, N. L. Martin, and D. W. Wara. 1994. HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 10:781.
6. Sastry K. J., H. R. Reddy, R. Pandita, K. Totpal, and B. B. Aggarwal. HIV-1 tat gene induces tumor necrosis factor-β (lymphotoxin) in a human B-lymphoblastoid cell line. 1990. J. Biol. Chem. 265:20091.
7. + T lymphoid (H9) cell line. AIDS Res. Hum. Retroviruses 11:31.
8. Puri, R. K., and B. B. Aggarwal. 1992. Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 52:787.
9. Lotz, M., I. Clark-Lewis, and V. Ganu. 1994. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J. Cell Biol. 124:365.
10. Dhawan, S., R. K. Puri, A. Kumar, H. Duplan, J-M. Masson, and B. B. Aggarwal. 1997. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90:1535.
11. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
12. Ensoli B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674.
13. Blenis J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl Acad. Sci. USA 90:5889.
14. Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553.
15. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
16. Karin M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.
17. Demarchi F., d'Adda di Fagagna, A. Falaschi, and M. Giacca. 1996. Activation of transcription factor NF-κB by the Tat protein of human immunodeficiency virus type 1. J. Virol. 70:4427.
18. Conant K., M. Ma, A. Nath, and E. O. Major. 1996. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes. J. Virol. 70:1384.
19. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213.
20. Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025.
21. Natarajan, K., S. Singh, T. R. Burke, Jr., D. Grunberger, and B. B. Aggarwal. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc. Natl. Acad. Sci. USA 93:9090.
22. Sluss, H. K., T. Barrett, B. Derijard, and R. J. Davis. 1994. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14: 8376.
23. Chen, Y. R., X. Wang, D. Templeton, R. J. Davis, and T. H. Tan. 1996. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation: duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:31929.
24. Yu, R., J.-J. Jiao, J.-L. Duh, T. H. Tan, and A.-N. T. Kong. 1996. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Cancer Res. 56:2954.
25. Stevens, A. M., Y.-f. Wang, K. A. Sieger, H.-f. Lu, and L.-y. Yu-Lee. 1995. Biphasic transcriptional regulation of the interferon regulatory factor-1 gene by prolactin: involvement of gamma-interferon-activated sequence and Stat-related proteins. Mol. Endocrinol. 9:513.
26. Sadaie, M. R., E. Tschachler, K. Valerie, M. Rosenberg, B. K. Felber, G. N. Pavlakis, M. E. Klotman, and F. Wong-Staal. 1990. Activation of tat-defective human immunodeficiency virus by ultraviolet light. New Biol. 2:479.
27. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells: a mechanism of HIV pathogenesis. J. Immunol. 156:1638.
28. Sato, H., and M. Sieki. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression, which is associated with invasiveness of tumor cells. Oncogene 8:395.
29. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptnsis by HIV-1 Tat and gp120. Nature 375:497.
30. Sastry, K. J., M. C. Marin, P. N. Nehete, K. McConnell, A. K. El-Naggar, and T. J. McDonnell. 1996. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 13:487.
31. McCloskey, T. W., M. Ott, E. Tribble, S. A. Khan, S. Teichberg, M. O. Paul, S. Pahwa, E. Verdin, and N. Chirmule. 1997. Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158:1014.
32. Chen, Y. R., C. F. Meyer, and T. H. Tan. 1996. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem 271:631.
33. Ensoli, B., L. Bounaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:277.
34. Gutheil, W. G., M. Subramanyam, G. R. Flentke, D. G. Sanford, E. Munoz, B. T. Huber, and W. W. Bachovchin. 1994. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc. Natl Acad. Sci. USA 91:6594.
35. Muller, J. M., R. A. Rupec, and P. A. Baeuerle. 1997. Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods 11: 301.
36. Schulze-Osthoff, K., M. Los, and P. A. Baeuerle. 1995. Redox signaling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem. Pharmacol. 50:735.
37. Staal, F. J., M. Roederer, L. A. Herzenberg, and L. A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87:9943.
38. Schreck R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1181.
39. Palmer G. H., J. Machado, P. Fernandez, V. Heussler, T. Perinat, and D. A. Dobbelaere. 1997. Parasite-mediated nuclear factor kappa B regulation in lymphoproliferation caused by Theileria parva infection. Proc. Natl. Acad. Sci. USA 94:12527.
40. Roederer, M., S. W. Ela, F. J. Staal, L. A. Herzenberg, and L. A. Herzenberg. 1992., N-acetylcysteine: a new approach to anti-HIV therapy. AIDS Res. Hum. Retroviruses 8:209.
41. Li, C. J., Y. Ueda, B. Shi, L. Borodyansky, L. Huang, Y. Z. Li, and A. B. Pardee. 1997. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc. Natl. Acad. Sci. USA 94:8116.
42. Ott, M., S. Emiliani, C. Van Lint, G. Herbein, J. Lovett, N. Chirmule, T. McCloskey, S. Pahwa, and E. Verdin. 1997. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275: 1481.